Valneva to host symposium on covid-19 and chikungunya vaccine candidates at 31st european congress of clinical microbiology & infectious diseases

Saint herblain ( france), july 5 , 2021 –valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need, announced today it will host a virtual symposium titled, “developing new vaccines to protect against infectious diseases at home and abroad” on july 9, 2021 at 14:15 cest at the 31st european congress of clinical microbiology & infectious diseases (eccmid).
VALN Ratings Summary
VALN Quant Ranking